Treatment regimens using anti-NKG2A antibodies

• 收藏
• 分享

专利权人:

Innate Pharma

发明人:

Andre, Pascale,Blery, Mathieu,Paturel, Carine,Soulas, Caroline,Wagtmann, Nicolai

申请号：

AU2015316993

公开号：

AU2015316993A1

申请日:

2015.09.15

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The present invention relates to methods for the treatment of disease, notably cancer, using antibodies that specifically bind and inhibit human NKG2A. Included are therapeutic regimens that provide improved efficacy of anti-NKG2A antibodies.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/